Senate Confirms Trump’s Drug Czar Nominee Who Backs Medical Cannabis

Big news for the community: the Senate just gave the thumbs up to Sara Carter Bailey as the new White House drug czar. This is a major win because Bailey isn’t your typical anti-cannabis bureaucrat. She has already voiced strong support for medical marijuana and says she is fine with regulated legalization, viewing the whole issue as a bipartisan common-sense move. As the director of the ONDCP, she will be steering the ship just as the administration works on rescheduling cannabis to Schedule III. Bailey has a background in journalism, specifically looking into the nasty chemicals and cartel activity in the illicit market. This means she is likely to prioritize consumer safety and legitimate, clean products over just slamming the door on the industry. For everyday tokers, this is huge. Having a drug czar who respects medicinal needs and safety standards means we are one step closer to a federal landscape that prioritizes patients and quality over prohibition. It is a solid sign that the conversation in D.C. is finally shifting toward a more practical, pro-access reality.